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Abstract
The critical stem cell transcription factor FoxD3 is expressed by the premigratory and migrating neural crest, an embryonic
stem cell population that forms diverse derivatives. Despite its important role in development and stem cell biology, little is
known about what mediates FoxD3 activity in these cells. We have uncovered two FoxD3 enhancers, NC1 and NC2, that drive
reporter expression in spatially and temporally distinct manners. Whereas NC1 activity recapitulates initial FoxD3 expression in
the cranial neural crest, NC2 activity recapitulates initial FoxD3 expression at vagal/trunk levels while appearing only later in
migrating cranial crest. Detailed mutational analysis, in vivo chromatin immunoprecipitation, and morpholino knock-downs
reveal that transcription factors Pax7 and Msx1/2 cooperate with the neural crest specifier gene, Ets1, to bind to the cranial
NC1 regulatory element. However, at vagal/trunk levels, they function together with the neural plate border gene, Zic1, which
directly binds to the NC2 enhancer. These results reveal dynamic and differential regulation of FoxD3 in distinct neural crest
subpopulations, suggesting that heterogeneity is encrypted at the regulatory level. Isolation of neural crest enhancers not only
allows establishment of direct regulatory connections underlying neural crest formation, but also provides valuable tools for
tissue specific manipulation and investigation of neural crest cell identity in amniotes.
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Introduction
The neural crest (NC) is a transient population of cells that
migrates throughout the embryo and forms many different cell
types, including neurons and glia of the peripheral and enteric
nervous systems, bone and cartilage of the craniofacial skeleton
and melanocytes [1,2]. Induction of the neural crest is thought to
involve a number of growth factors, including Wnts and BMPs,
that establish the neural plate border region that contains the
prospective neural crest. This region is characterized by the
collective expression of a number of transcription factors,
including Msx1/2, Pax3/7 and Zic1, termed neural plate border
genes [3]. Subsequently, as neurulation progresses, additional
transcription factors are expressed by neural crest precursors
residing within the neural folds and dorsal neural tube. These
transcription factors, termed neural crest specifier genes, include
Sox9, FoxD3, Ets1, Snail1/2 and Sox10, amongst others [2].
Regulatory interactions between neural plate border genes, neural
crest specifier genes and signaling inputs generate a complex gene
regulatory network (GRN) that orchestrates essential steps in
neural crest ontogeny, including emigration from the neural tube,
migration to appropriate locations and differentiation into many
different cell types.
An important challenge is to establish direct connections within
the neural crest GRN. For example, the neural plate border
marker, Pax7, is essential for expression of a number of different
neural crest specifier genes [4] such that its loss-of-function results
in the subsequent loss of Sox10 and Snail2 in the cranial neural
crest. Thus, these genes act downstream of Pax7, either by direct
or indirect interactions. For the case of Sox10, regulatory analysis
revealed direct inputs from Sox9, Ets1 and Myb, but not Pax7 [5],
suggesting that effects of loss of Pax7 on Sox10 expression are
likely to be indirect. This raised the question of what genes might
be direct targets of neural plate border genes like Pax7.
Of the neural crest specifier genes, FoxD3 is one of the first
markers of premigratory neural crest in many vertebrate species
including mouse, chick, Xenopus and zebrafish [6–12]. Its initial
expression in the neural tube precedes that of Sox10 and several
pieces of evidence suggest that FoxD3 is critical for initiating a
cascade of neural crest gene expression that controls their
emigration from the neural tube. For example, ectopic expression
of FoxD3 in the chick neural tube induces expression of neural
crest markers and increases emigration from the neural tube [13].
Similarly in Xenopus ectopic expression at the 8-cell stage increases
the expression of neural crest markers, while expression of
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dominant-negative FoxD3 reduces expression of genes like Snail2,
Twist and Ets1 [11] and depletes some neural crest derivatives
[9,11,14,15].
Despite its important role both in stem and neural crest cells, no
regulatory element(s) controlling the onset of FoxD3 expression
are known. To define linkages and assess direct regulatory
interactions in the neural crest gene regulatory network with
particular interest in possible targets of Pax7, we set out to dissect
the cis-regulatory regions of the critical neural crest gene, FoxD3.
Taking advantage of the chick’s compact genome and ability to
assay putative regulatory regions by electroporation, we have
identified two enhancers, NC1 and NC2, that mediate reporter
expression in spatially and temporally distinct manners in the
chick embryo, and in combination closely recapitulate the
endogenous expression of FoxD3. Detailed regulatory analysis
shows that initial expression of FoxD3 in both cranial and trunk
neural crest requires direct input from neural plate border genes,
Pax7 and Msx1/2. These factors function in combination with the
neural crest specifier gene, Ets1, to bind to the cranial NC1
regulatory element. However, at vagal/trunk levels, they function
together with the neural plate border gene Zic1 to activate the
NC2 enhancer. These results not only reveal region-specific
enhancer activity in the neural crest, but also expand the neural
crest GRN and inform upon direct interactions therein. Conserved
between mouse and chick, these enhancers further provide
excellent tools for assaying gene regulation and manipulation of
neural crest gene expression in amniotes.
Results
Endogenous pattern of chick FoxD3 expression in the
neural crest
In the cranial neural tube, expression of FoxD3 initiates in
premigratory neural crest cells at HH8- (Figure 1A), with strong
and rapid onset of expression that precedes that of Sox10 or
Snail2. At this stage, the FoxD3 expression domain includes the
neural folds of the forebrain and midbrain. Subsequently, at
HH8+, FoxD3 expression expands posteriorly to the hindbrain
(Figure 1B). As neural crest cells delaminate at HH9 and migrate
at stage 10, FoxD3 is maintained or expressed de novo at high levels
by many migrating cranial crest cells (Figure 1C, 1D). The domain
of expression of FoxD3 at this stage includes premigratory and
migratory crest extending from the midbrain to the trunk, with the
exception of the neural folds at the level of rhombomere 3 (dotted
arrow in Figure 1C). Expression persists through subsequent stages
as the neural crest advances to surround the optic vesicle and
populate the first branchial arch.
At vagal and trunk levels, FoxD3 is also expressed by
premigratory and migrating neural crest cells. FoxD3 transcript
expression initiates as the neural folds appose in the midline at
stage HH9. At HH12, FoxD3 is detected in migrating vagal crest
as the first wave of cells leaves the neural tube (white arrow in
Figure 1I) and with time, FoxD3 expression initiates at progres-
sively more caudal levels in the trunk neural tube and migrating
neural crest. At later stages, FoxD3 expression is maintained in a
subset of neural crest derivatives, including peripheral ganglia
[16].
Double fluorescent in situ hybridization for FoxD3 and Sox10
reveals differences in the expression domains of these neural crest
specifier genes. FoxD3 transcripts are detected in the premigratory
population prior to Sox10, which is expressed in cranial, vagal and
trunk neural crest cells only as cells leave the neural tube (arrows
on Figure 1E and 1F). Therefore, even though FoxD3 and Sox10
both have been placed in the same hierarchical level in the neural
crest GRN, they are recruited at different time points during
neural crest specification.
Dissection of the FoxD3 regulatory region
The genomic region of FoxD3 was examined for conservation
across multiple vertebrate taxa including chick, mouse, human,
opossum, Xenopus and zebrafish using the UCSC Genome Browser
and ECR Browser. The region analyzed spanned 160 kb between
the genes immediately up and downstream of FoxD3, Atg4C and
Alg6 respectively (Figure 1O). To test putative enhancers for
neural crest regulatory activity, eighteen conserved regions varying
in size from 1 kb to 4 kb were cloned into an eGFP reporter vector
[17] and electroporated into the entire epiblast of stage HH4 or
dorsal neural tube of HH8–14 chick embryos, together with pCI-
H2B-RFP as a ubiquitous tracer to verify efficacy of transfection.
Two enhancers, NC1 and NC2, mediate different spatial
and temporal expression patterns in the neural crest
By testing conserved regions within the FoxD3 locus, we found
two enhancers that drive specific expression of eGFP in the neural
crest, in a manner that collectively closely recapitulates the
endogenous pattern of FoxD3 expression. Enhancer NC1 directed
expression of eGFP in the premigratory cranial neural crest
analogous to the early endogenous expression of FoxD3
(Figure 1G–1H). eGFP in the cranial neural folds was detected
from stage HH8+ (Figure 1G), in the dorsal neural tube and on a
few neural crest cells during emigration (Figure 1H, 1J, 1L), lasting
until approximately stage HH14, at which time only very weak
eGFP expression could be detected. While migrating neural crest
from the midbrain to rhombomere (R) 2 exhibited NC1 mediated
eGFP expression (Figure 1J), no eGFP expression was observed
caudal to R3. This contrasts with the endogenous FoxD3 pattern,
which is observed in R4, R6 and more posterior crest (Figure 1I).
Enhancer NC2, in contrast to NC1, mediated strong eGFP
expression in the premigratory, delaminating and migrating neural
crest at and caudal to R6 (Figure 1K), beginning at HH9. This
expression pattern of eGFP in the vagal and trunk neural crest
recapitulates endogenous expression of FoxD3 (Figure 1I) at this
Author Summary
FoxD3 is an important stem cell factor expressed in many
types of embryonic cells including neural crest cells. In the
embryo, neural crest cells are a type of stem cell that forms
diverse derivatives, including nerve cells, pigment cells,
and facial structures. To better understand neural crest
development and differentiation, we have explored how
FoxD3 expression is regulated in these cells. By examining
non-coding DNA, we have identified distinct genomic
regions that mediate expression of green fluorescent
protein (GFP) in a pattern that recapitulates FoxD3
expression. Interestingly, we find two genomic ‘‘on–off’’
switches or enhancers, called NC1 and NC2, that drive GFP
expression in a pattern that recapitulates FoxD3 expres-
sion at different times and places during neural crest
development. We find that Pax and Msx proteins turn on
both NC1 and NC2 enhancers by directly binding to them.
In addition, cranial expression driven by NC1 requires a
protein called Ets1, whereas trunk expression of NC2
requires a different protein called Zic1. The results show
that FoxD3 in differentially regulated in distinct neural
crest cell populations in a manner that is specifically
encoded in the genome. These enhancers provide valu-
able tools for understanding neural crest development in
birds and mammals.
Regulation of FoxD3 in the Neural Crest
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axial level. The expression of both eGFP and endogenous FoxD3
mRNA extends to the premigratory/delaminating crest at the level
of the 4th most caudal somite. Interestingly NC2 activity also
controlled eGFP expression in a large subpopulation of migrating
cranial neural crest at the level of the midbrain, R1 and R2, which
was detectable only after stage HH9+, and expression in
premigratory and migratory NC from R4.
To examine the activity of NC2 enhancer at later stages and in
neural crest derivatives, we electroporated stage HH8–14 embryos
in ovo, and fixed the embryos after 24–48 h (HH15–20). FoxD3 is
expressed in most premigratory and migratory vagal and trunk
neural crest, but is down-regulated in melanoblasts (Figure S1A),
which migrate underneath the ectoderm and initiate emigration
approximately 24 h after the emigration of ganglionic neural crest
in the chick. Interestingly, we observed expression of eGFP in
melanoblasts prior to and during migration (Figure S1B), in
addition to expression in the dorsal root and trigeminal ganglia.
To confirm that this expression was due to activity of the enhancer
and not stability of eGFP, we performed in situ hybridization for
eGFP and detected mRNA for eGFP in melanoblasts and dorsal
root ganglia (Figure S1D–S1E), suggesting that eGFP is indeed
ectopically expressed by melanoblasts, under control of the NC2
enhancer. Expression of eGFP was also seen in neural crest cells
migrating along the enteric neural crest pathway (Figure S1F). In
contrast to NC2, at HH14 very weak expression of NC1 activity
was confined to the branchial arches whereas no expression was
observed in cranial ganglia.
We next examined overlap of endogenous FoxD3 expression
with reporter expression driven by NC1 and NC2 by performing
double labeling with eGFP and FoxD3 antibodies. The results
Figure 1. Endogenous FoxD3 in the neural crest is reflected by activity of two enhancers, NC1 and NC2. (A) Expression of FoxD3 in
premigratory neural crest cells at HH82. (B) At HH8+, FoxD3 expression extends to the midbrain and hindbrain neural folds. (C) At HH9, FoxD3 is
expressed by premigratory and migrating neural crest cells, at cranial, vagal and trunk levels with the exception of rhombomere 3 (dotted arrow). (D)
FoxD3 transcripts are detected in migrating cranial crest cells at stage HH10. (E–F) Double fluorescent in situ hybridization for Sox10 (red) and FoxD3
(green) reveals differences in the expression domains of these neural crest specifiers at stages HH9 (E) and HH10 (F). Expression of Sox10 begins only
as cells leave the neural tube at all axial levels. (G–H) Expression of eGFP driven by enhancer NC1 at stages HH8+ and HH10. Bar indicates
approximate level of transverse section shown in L. (I) In situ hybridization of FoxD3 at stage HH12. (J) Expression of eGFP driven by enhancer NC1. (K)
eGFP driven by enhancer NC2. (L–N) Transverse sections through embryos shown in H, J, K. Arrows indicate migratory neural crest expressing eGFP.
HNK-1-positive cells shown are in blue in M and N. (O) Genomic region of FoxD3 in chick showing regions tested for enhancer activity between the
flanking genes Atg4c and Alg6 (blue boxes). Boxes indicate regions that were tested for enhancer activity: black boxes indicate no detectable activity
in the neural crest; green boxes indicate enhancers active in the neural crest. Coding regions are indicated by blue boxes. anf: anterior neural fold,
not: notochord, nf: neural fold, nc: neural crest, ncc: neural crest cells, nt: neural tube, ot: otic placode, R: rhombomere.
doi:10.1371/journal.pgen.1003142.g001
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show that NC1-driven eGFP expression completely overlapped
with that of endogenous FoxD3 protein in stage HH9 embryos
(Figure 2A–2C). Similarly, NC2-driven eGFP expression in
migrating cranial neural crest overlapped with endogenous FoxD3
protein expression at stage 11 (Figure 2D–2F) and with FoxD3 in
delaminating and migrating crest at the trunk/vagal levels at stage
12 (Figure 2G–2H). The complete overlap between enhancer
activity and FoxD3 expression strongly suggests that NC1 and
NC2 are the responsible regulatory modules for the control of
endogenous FoxD3 in the neural crest.
To determine if orientation of the enhancers affects their
activity, NC1 and NC2 enhancers were cloned in reverse
orientation into ptk-eGFP and electroporated in HH4 embryos.
The results show that both have equivalent ability to drive reporter
expression in reversed as in their endogenous orientation, without
significant changes in pattern or levels of activity (Figure 2J, 2K).
Finally, we examined whether these enhancers were conserved
across amniotes. To this end, we cloned the homologous
conserved regions from the mouse genome and mouse (m) NC1
and mNC2 constructs were electroporated into chick embryos at
gastrula stages. The results show that the patterns of eGFP
expression driven by mNC1 and mNC2 were identical to those
observed with chick NC1 and NC2 (Figure 2L, 2M), suggesting
that these enhancers are conserved between chick and mouse and
likely throughout amniotes.
Dynamic analysis of NC1 and NC2 reporter expression
To examine the dynamic nature and combined activity of the
two enhancers in the migrating cranial neural crest, we co-
electroporated NC1 (green) and NC2 (blue) enhancers in
combination with a previously identified cranial neural crest
Sox10E element (red) [5] that expresses in all emigrating and
migrating neural crest cells. Reporter expression of multiple
fluorophores was then visualized in transverse sections of slices
through the midbrain region, using a novel slice culture protocol
[18].
Time-lapse movies revealed differential temporal and spatial
activity of NC1 and NC2 enhancers. While NC1 activity was
present in the premigratory neural crest, the expression it drove in
the dorsal neural tube appeared transient in most cells and
preceded that driven by the Sox10E enhancer (white arrow in
Figure 3A). NC1 activity then recurred in a small subpopulation of
Figure 2. Chick NC1 and NC2 enhancers drive expression that overlaps with endogenous FoxD3 expression, function in reverse
orientation, and are conserved with mouse NC1 and NC2. (A–C) Immunostaining with anti-FoxD3 antibody (red) of embryos electroporated
with NC1:eGFP (green) shows overlap of enhancer activity and endogenous expression of FoxD3 in early cranial neural crest cells. (D–F) Migrating
cranial neural crest cells express FoxD3 and eGFP driven by the NC2 enhancer in stage HH11 embryos. (G–I) Vagal and trunk neural crest cells that are
positive for FoxD3 also express eGFP driven by the FoxD3 enhancer. (J–K) Reversing the orientation of NC1 and NC2 does not alter their ability to
drive eGFP expression. (L–M) Genomic regions homologous to the NC1 and NC2 enhancers cloned from mouse (mNC1 and mNC2) drive expression
of eGFP in a manner identical to chick NC1 and NC2. cnc: cranial neural crest, vnc: vagal neural crest, tnc: trunk neural crest.
doi:10.1371/journal.pgen.1003142.g002
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Figure 3. Dynamic regulation of FoxD3 and Sox10 enhancers in the cranial neural crest. (A–D) Selected images from a time lapse
sequence showing activity of the NC1 (green) and NC2 (blue) FoxD3 enhancers and the Sox10E2 (red) enhancer in a chick cranial slice preparation
(see Video S1). (E–H) Images from a time lapse movie of migrating cranial neural crest cells electroporated with NC1:eGFP and NC2:Cherry (see Video
S2).
doi:10.1371/journal.pgen.1003142.g003
Regulation of FoxD3 in the Neural Crest
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actively migrating cranial crest cells that concomitantly displayed
Sox10E activity (black arrows in Figure 3B and 3C, Video S1). In
contrast, NC2 activity was observed in very few cells within the
neural tube (red arrow in Figure 3C), and only a few delaminating
neural crest cells coincident with Sox10E activation. Thereafter,
NC2 drove expression in a large subset of migrating cranial neural
crest cells, which were also positive for Sox10E activity (black
arrows in Figure 3C and 3D).
To further investigate neural crest heterogeneity with respect to
enhancer-driven expression, we co-electroporated embryos with
NC1 (green) and NC2 (red) enhancers and observed neural crest
formation and migration by time lapse microscopy. Analysis of the
movies suggested that there was little overlap between cells
showing activity of NC1 and those with NC2 (Figure 3E–3H,
Video S2). Only a few cells co-expressed eGFP and RFP and this
may reflect perdurance of the reporter that may be more stable
than the endogenous transcription factor. These results suggest
that there is highly dynamic regulation of FoxD3 in migrating
neural crest cells and suggest that there may be distinct
subpopulations that reflect activity of NC2 but not NC1, or vice
versa. They further suggest that NC1 activity may be largely
responsible for the transient early expression of FoxD3 in the
neural tube (arrow in Figure 3F), whereas NC2 activity at cranial
levels may be primarily responsible for FoxD3 expression in
migrating neural crest cells (arrows in Figure 3G and 3H).
A conserved 80 bp element is the minimal essential core
regulatory element of enhancer NC1
The dynamic expression driven by the enhancer NC1 and its
early activation, correlating with the onset of endogenous FoxD3,
led us to explore upstream regulators and their binding motifs
within NC1, responsible for early activation in the premigratory
neural crest. To this end, conservation across vertebrates was used
as a guide to identify putative core regions within the enhancer.
The central region of NC1 was highly conserved with human,
mouse and Xenopus, but showed no sequence conservation with
zebrafish. Primers were designed to amplify fragments of NC1,
which were tested for activity at stages HH9–10, corresponding to
the time it drove strongest expression. Using this approach, NC1
was reduced to 553 bp (NC1.1) without loss of activity (Figure 4A,
Figure 4. Dissection of the NC1 and NC2 enhancers. (A, H) Diagram of deletions and substitutions made to uncover critical enhancer regions.
Each numbered bar represents a region of the enhancer that was tested via whole embryo electroporation. The relative level of expression in cranial
and vagal/trunk neural crest (NC) is indicated on the right for each region ranging from + indicating weak expression to +++++ indicating strong
expression. Gray bars indicate those enhancer regions that drove activity in the neural crest. Red bars indicate a lack of activity. Black fragments of the
enhancer indicate substitution with GFP coding sequence. NC1.3 and NC1.4 contain the core region of the enhancer NC1 (dashed box). (B–G, I–L)
Whole mount dorsal view of examples of the different constructs and effects of mutations. eGFP expression (green) indicates enhancer activity in
electroporated (red) cells. (B,C) NC1.1 directs expression of eGFP in the same pattern as full-length NC1. (D,E) NC1.2 drives weak expression of eGFP in
cranial neural crest. (F,G) NC1.1 M7 only drives weak eGFP expression in a small number of cells in no discernable pattern. (I, J) NC2.9 directs
expression of eGFP in the same pattern as full-length NC2. (K,L) NC2.9 M11, containing a deletion of the Zic site, fails to drive eGFP in the neural crest.
nc: neural crest, R: rhombomere.
doi:10.1371/journal.pgen.1003142.g004
Regulation of FoxD3 in the Neural Crest
PLOS Genetics | www.plosgenetics.org 6 December 2012 | Volume 8 | Issue 12 | e1003142
4B). A further deletion to 303 bp (NC1.2) resulted in weak eGFP
expression specifically in the cranial neural crest (Figure 4A, 4D),
suggesting that the regions at the ends of NC1.1 amplify activity of
the enhancer, although the critical regions are present within
NC1.2. The sequence of NC1.2 was further analyzed by
substituting 100 bp regions of sequence with eGFP coding
sequence within the NC1.1 fragment. eGFP coding sequence
was chosen as a random sequence to substitute for enhancer
regions, so that the size and spacing was maintained, but did not
alter expression in control experiments. This analysis revealed that
200 bp was required for expression mediated by the enhancer
(Figure 4A). We then substituted 20 bp blocks of sequence with
eGFP coding sequence across this region within NC1.1. This
analysis revealed a region of 80 bp that was critical for detectable
expression of eGFP (Figure 4A). An adjacent 92 bp region was
required as a unit for eGFP expression; however substitutions of
20 bp blocks within this secondary region weakened but did not
eliminate eGFP expression. None of the substitutions resulted in
expansion of enhancer-driven expression. The 172 bp fragment
(NC1.3) containing the most critical and supportive regions was
amplified and electroporated into embryos, and the 80 bp putative
core region (NC1.4) was tested by placing two copies in tandem
into the ptkeGFP construct. NC1.3 alone drove very weak
expression of eGFP in the neural crest. Interestingly, the NC1.4
cancatamer was sufficient to drive eGFP expression in the same
pattern as the full-length NC1 enhancer, albeit slightly weaker,
suggesting that the 80 bp NC1.4 fragment contains the core
elements essential for activity of this enhancer.
Potential transcription factor binding sites within the core
region were identified using Rvista and Jaspar databases (Figure
S2A). Mutations were made to these sites by substituting 6–8 bp of
the core binding site (marked in red or blue in Figure S2A).
Mutations to the Ikaros binding site or to the Ets/Zeb binding site
did not affect expression of eGFP (Figure S2B and S2C). In
contrast mutation of the homeodomain site (Figure S2D and S2E)
or Elk/Ets site resulted in loss of eGFP expression. Additionally,
mutation of an Msx site (Figure S2A) reduced activity of the
enhancer. Pax7, Msx1 and Msx2 are neural plate border genes
expressed in the neural folds prior to expression of FoxD3, and
candidates for direct activators of FoxD3. All of these can
potentially bind to the homeodomain sites. Furthermore, Ets1 is
expressed specifically in the cranial neural crest concomitant with
the onset of FoxD3 expression.
Dissection of NC2 reveals Zic binding sites are critical for
enhancer activity
Similar to the dissection of NC1, we performed a series of
deletions and substitutions to identify the core structure critical for
activity of the NC2 enhancer (Figure 4H). NC2 is highly conserved
in mouse, human, Xenopus and zebrafish. Stepwise deletions
revealed a fragment, termed NC2.9, with similar albeit weakened
activity to that seen with NC2 in the vagal and trunk neural crest,
as well as weak activity in cranial migratory neural crest
(Figure 4H, 4I). Subsequently, 100 bp and 30 bp substitutions
were made within NC2.9, narrowing the essential regions of the
enhancer to approximately 120 bp, encompassing a 90 bp core
region surrounded by auxiliary regions required for strong
expression (Figure 4H). Several deletions of the NC2 enhancer
resulted in eGFP expression in the developing retina (NC2.6,
NC2.9 M20) and otic vesicle (NC2.7), and using the full-length
NC2 enhancer to drive eGFP, occasional weak expression could
also be seen in these structures.
Importantly, deletion of the Zic site within the 90 bp critical
core region resulted in complete loss of activity of the enhancer
(Table S1). The auxillary (amplifying) region contains Pax, Ets and
SoxE sites. Deletion of Pax or SoxE binding sites in the auxiliary
region caused loss of NC2 activity in cranial neural crest, but did
not affect vagal/trunk NC2 activity (Table S1). Similarly, deletion
of an Ets1 site in the auxiliary region (M20), abolished activity in
R1–R3 of the cranial neural crest, but did not affect vagal/trunk
activity (Table S1). The results suggest that the NC2 enhancer
itself is differentially regulated in the cranial neural crest versus
trunk neural crest.
Knock-down of potential regulators reveals differential
control of NC1 and NC2
We next tested whether the putative transcription factors
implicated by enhancer dissections could regulate enhancer driven
reporter expression. To this end, individual embryos were
electroporated on one side with FITC-conjugated control
morpholino plus enhancer directing Cherry expression and with
FITC-conjugated blocking morpholino plus enhancer-Cherry on
the contralateral side.
For NC1, morpholino-mediated loss of Pax7 (Figure 5B, 5K)
protein resulted in significant loss of reporter expression on the
target morpholino side (right). Whereas Msx1 knock-down alone
resulted in a mild loss of Cherry expression and Msx2 knock-down
had almost no phenotype (data not shown), the double MO knock-
down exhibited a strong loss of reporter expression (Figure 5C,
5K). Additionally, knock-down of the transcription factor Ets1
resulted in strong loss of NC1 enhancer activity (Figure 5D, 5K).
In contrast, morpholinos against other neural crest or neural plate
specifiers like Zic1 (Figure 1E), Sox9 or AP-2 failed to alter NC1
reporter expression. These findings support the possibility that
Pax7, Msx1/2, and Ets1 are direct inputs into the NC1 enhancer.
To confirm that the loss of Cherry positive cells was not due to
loss of neural crest cells on the morpholino-treated side of the
embryo, we examined other neural crest markers in embryos in
which enhancer-driven Cherry expression was depleted (Figure
S3). At the concentration of morpholinos used, we observed little
change in Sox9 expression (Figure S3G–S3I), demonstrating that
the neural crest population was present in morpholino-treated
embryos. Similarly, immunostaining with the HNK-1 antibody at
stage HH10 confirmed the persistence of neural crest cells after
morpholino treatment (Figure S3J–S3L).
We next examined the effects of knocking down putative
regulators on expression driven by the NC2 in the vagal/trunk
neural crest. Electroporation of both Pax7 and Msx1/2 morpho-
linos resulted in loss of NC2 activity in the trunk neural crest
(Figure 5G, 5H, 5L) similar to the effects observed for NC1 activity
in the cranial crest. In addition, electroporation of the Zic1
morpholino caused strong loss of NC2 activity specifically in the
trunk (Figure 5J, 5L), suggesting this transcription factor is a key
player in the regulation of trunk expression of FoxD3. On the
other hand, Ets1 knock-down had no affect on trunk activity of
NC2, which is not surprising given that this transcription factor is
not expressed in the posterior neural crest (Figure 5I, 5L). Taken
together, these results place Pax7 and Msx1/2 as general
regulators of FoxD3 expression, while Ets1 and Zic1 seem to
specifically regulate NC1 and NC2, respectively.
Endogenous FoxD3 activity is affected by knockdown of
Pax7, Ets1, Msx1/2, and Zic1
To examine the effects of these regulators on endogenous gene
expression, we performed morpholino-mediated loss-of-function of
Pax7, Ets1, Msx1/2 and Zic1 and examined endogenous FoxD3
expression in newly forming cranial and trunk neural crest cells.
Regulation of FoxD3 in the Neural Crest
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Detection of FoxD3 was assessed by hybridization chain reaction
(HCR), which reflects transcript levels more accurately than in situ
hybridization and at subcellular resolution [19]. We found that
morpholino mediated knock-down of Msx1/2, Pax7 and Ets1
caused a significant loss of cranial FoxD3 expression (Figure 6A–
6C) at stage HH9, but not Sox9 or HNK-1 expression.
At trunk levels, knock-down of Msx1/2, Pax7 and Zic1 resulted
in a significant reduction of endogenous FoxD3 expression
Figure 5. Knockdown of several putative inputs affects activity of NC1 and NC2 enhancers. (A,F) The left side of each embryo was
electroporated with control morpholino plus a construct containing either NC1 (A–E) or NC2 (F–J) driving Cherry. The right side of each embryo was
electroporated with the same construct plus indicated antisense morpholino. Knockdown of Pax7 (B), Msx1+2 (C), or Ets1 (D) results in dramatic loss
of NC1.1 activity, whereas Zic1 morpholino (E) has no effect. In contrast, Pax7 (G), Msx1/2 (H) and Zic1 (J) have a strong effect on activity of the NC2
enhancer in the trunk, while Ets1 has no effect (I). (K, L) Percentage of embryos that showed either mild or strong reduction of Cherry expression on
the side electroporated with antisense morpholino.
doi:10.1371/journal.pgen.1003142.g005
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Figure 6. Effect of morpholino-mediated knockdown and chromatin immunoprecipitation. (A–I) Effect of morpholino-mediated
knockdown of Pax7, Msx1/2, Ets1 and Zic1 on the endogenous expression of FoxD3. Knockdown of Pax7 (A), Msx1/2 (B) and Ets1 (C) results in
reduction of endogenous expression of FoxD3 in the cranial neural crest. In trunk neural crest cells, electroporation of morpholinos to Pax7 (D), Msx1/
Regulation of FoxD3 in the Neural Crest
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(Figure 6D–6F), whereas loss of Ets1 had no effect. The results
show that Pax, Msx and Zic transcription factors are not only
important for mediating enhancer activity but also for endogenous
expression of FoxD3 in the vagal/trunk neural crest.
Pax7, Ets1, Msx1/2, and Zic1 directly regulate FoxD3
through the NC1 and NC2 enhancers
To demonstrate in vivo association of Pax7, Msx1 and Ets1
transcription factors with the NC1 enhancer, we performed
quantitative chromatin immunoprecipitation (ChIP) experiments.
Cross-linked chromatin isolated from the midbrain dorsal neural
tube of HH8–9 embryos was immunoprecipitated using Pax7,
Msx1 and Ets1 antibodies and ChIP-enriched DNA was used in
site-specific qPCR, with primers designed to amplify fragments
within the NC1 region. For all three factors, we found significant
enrichment of the NC1 region amplicon, expressed as a percent of
the total input chromatin, compared to IgG controls (Figure 6G–
6I). No enrichment was detected in the negative control regions in
chromosome 8 (Figure 6G–6I), confirming they are direct inputs
into NC1. These data demonstrate that Pax7, Msx1 and Ets1 bind
in vivo to the NC1 enhancer element in the cranial neural crest.
Given the striking effects of Zic1 knockdown on NC2 activity in
the trunk region, we hypothesized that this transcription factor
directly binds this enhancer in vivo. To examine this, we dissected
dorsal trunk neural tubes of stage HH12 embryos, crosslinked and
immunoprecipitated chromatin with a Zic1 antibody. The results
show significant enrichment of the NC2 region amplicon,
expressed as a percent of the total input chromatin, compared to
IgG (Figure 6J). The results confirm that Zic1 directly associates
with the NC2 enhancer in trunk neural crest.
Taken together, these results reveal direct transcriptional
regulators of FoxD3 in the neural crest GRN, and highlight the
differential regulation of FoxD3 in the cranial and trunk neural
crest cells.
Discussion
As proposed in a putative gene regulatory network [3], FoxD3 is
predicted to be downstream of neural plate border specifier genes
such as Msx1/2, Pax3/7 and Zic1. Indirect support for this
regulatory connection comes from several previous studies. Mice
null for Pax3 lack expression of FoxD3 in the neural crest [13].
Knockdown of several genes in Xenopus, including Msx1, Pax3 and
Zic1 results in loss of FoxD3 expression in the neural crest [20–
22]. Similarly, knockdown of these genes and others expressed at
the neural plate border in lamprey result in loss of FoxD3
expression [23]. Conversely, misexpression of these genes can
induce expression of FoxD3 and other neural crest markers in
Xenopus [20–22]. However, little was known about direct binding
of any of these potential upstream transcription factors to a
regulatory region of FoxD3, or the exact placement of these genes
in relation to FoxD3 within the neural crest gene regulatory
network. Importantly, these studies did not consider that FoxD3
may be differentially regulated at different axial levels.
Multiple enhancers regulate dynamic FoxD3 expression
in the neural crest
Our results suggest that expression of FoxD3 is regulated in the
avian neural crest by at least two enhancers, which direct
expression in largely distinct spatiotemporal domains (head versus
vagal/trunk regions), as well as in different subpopulations of the
cranial neural crest. The enhancer NC1 is active in premigratory
and some migratory cranial neural crest rostral to R3, while
enhancer NC2 activity initiates in a single continuous wave caudal
to rhombomere 4, including vagal and trunk regions, but also later
in a subpopulation of migrating cranial neural crest. In our
analysis of the conserved regions within the FoxD3 locus, only
these two regions were able to mediate reporter expression in
patterns reflecting the distribution of neural crest. The proximity
of the NC1 and NC2 enhancers to the FoxD3 coding region, the
recapitulation of endogenous FoxD3 expression by the combined
activity of the enhancers, and the effect of manipulating upstream
regulators on both enhancers and endogenous FoxD3 expression,
strongly suggest that NC1 and NC2 act as enhancers regulating
endogenous expression of FoxD3 in the neural crest.
Comparison of the activity of these two enhancers with the
cranial Sox10 enhancer Sox10E2 [5] using time-lapse imaging
demonstrated for the first time that there is dynamic regulation of
multiple enhancers within a population of cranial neural crest
cells. We observed that the activity of the cranial NC1 enhancer is
initially restricted to cells in the dorsal neural tube; only later is it
activated de novo in actively migrating cranial neural crest cells,
where its activity is preceded by that of Sox10E2. NC2 is active in
only a few delaminating/emigrating cranial neural crest cells but
in a majority of the migrating neural crest population. Interest-
ingly, there is little overlap of NC1 and NC2 activity in the cranial
neural crest, whereas both overlap with Sox10E2, which appears
to be active in all of the migrating cranial crest population.
The minimal overlap in activity of NC1 versus NC2 in cranial
neural crest populations raises the interesting possibility that there
may be a regulatory switch of enhancers from NC1 to NC2 at the
endogenous promoter of FoxD3 when the cells reside within the
dorsal neural tube and/or are emigrating. Such competition at the
promoter could occur if only a single enhancer can be functional
at any given time on the FoxD3 promoter. If this is the case, the
very few double labeled cells expressing NC1- and NC2-driven
reporter expression may represent perdurance of eGFP protein
rather than the actual levels of enhancer activity. The finding that
NC1 and NC2 enhancers are active in generally separate cranial
neural crest populations further suggests that the cranial neural
crest represents a heterogeneous population, even as the cells are
delaminating from the neural tube, and that this heterogeneity
may be encrypted at the regulatory level.
It is intriguing to speculate that the differential activity of NC1 and
NC2 in distinct subpopulations may reflect differential cell fate and
commitment status of future neural crest derivatives. Consistent with
the possibility that NC1 and NC2 activity may reflect commitment
to different lineages, NC2 is later active in neural crest-derived dorsal
root and trigeminal ganglia, whereas NC1 is active transiently in the
branchial arches, but not in peripheral ganglia.
2 (E) and Zic1 (F) results in reduction of FoxD3 expression. (G–J) Chromatin immunoprecipitation shows direct binding of Pax7, Ets1, Msx1 to the NC1
enhancer and Zic1 to NC2 enhancer. Immunoprecipitation of chromatin isolated from the midbrain dorsal neural tubes of chicken embryos using
Pax7 (G), Msx1 (H) or Ets1 (I) antibodies was used in site-specific QPCR, with primers designed to amplify fragments within the NC1 region. The results
reveal significant enrichment of the NC1 region amplicon, expressed as a percent of the total input chromatin, compared to negative control regions.
(J) Immunoprecipitation of chromatin isolated from the trunk dorsal neural tubes of chicken embryos using Zic1 antibody reveals direct binding of
this transcription factor to the NC2 enhancer compared to negative control regions.
doi:10.1371/journal.pgen.1003142.g006
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The activity of NC2 in the vagal and trunk neural crest
recapitulated expression of endogenous FoxD3 in premigratory
and migratory neural crest cells. In addition, FoxD3 is retained by
a subset of neural crest derivatives [16]. Consistent with this,
conditional knockout of FoxD3 in neural crest cells using the
Wnt1-Cre line suggests that FoxD3 is required to maintain neural
crest progenitors and that its loss biases their derivatives toward a
mesenchymal fate at the expense of neural derivatives [24]. Thus,
it appears to regulate the switch between neural/glia and
melanocyte lineages [16].
NC2 not only was active in neuronal derivatives, but also
directed activity in neural crest cells migrating along the
dorsolateral pathway, which are melanocyte precursors that
migrate 24 h after the ventrolateral population migrate to the
ganglia. Cells on the dorsolateral population do not normally
express FoxD3 [7]. Thus, NC2 likely is missing a repressor region
for the pigment lineage that is present in the endogenous
regulatory region. In fact, ectopic expression of FoxD3 in
melanoblasts inhibits their migration onto the dorsolateral
pathway, while down-regulation of FoxD3 results in premature
dorsolateral migration and increases melanocyte differentiation in
cultured neural crest [7]. FoxD3 represses transcription of Mitf, a
key transcription factor required for melanocyte development
[16,25]. Our finding of an active enhancer in melanoblasts
suggests that FoxD3 is normally repressed in melanoblasts, and
this repression does not occur within the NC2 region. In the
zebrafish histone deacetylase 1 (hdac1) mutant, a severe loss of mitfa
positive melanophores can be rescued by partial reduction of
FoxD3; suggesting hdac1 is required to repress FoxD3 in
melanophores [25]. It is not yet clear whether this repression is
direct or indirect and if it is conserved across species.
At cranial levels, FoxD3 is regulated by Pax7 and Msx1/2
and Ets1, while trunk expression is dependent on Zic1
The current results establish for the first time a direct regulatory
connection between the neural plate border genes, Pax7 and
Msx1/2, and FoxD3, suggesting it is an immediate downstream
target. This confirms and validates previous indirect evidence in
Xenopus, lamprey and mouse, and provides further support for a
conserved gene regulatory network in the neural crest. Pax7 and
Pax3 are closely related paralogs which have overlapping
expression and function [26]. Pax3 and Pax7 bind identical
DNA binding domains, and while they show equal affinity for
binding to the paired domain, Pax7 shows a higher affinity for the
homeobox domain [27]. Both Pax3 and Pax7 are expressed in the
developing neural crest, but in overlapping and distinct regions of
the neural crest, and these patterns differ between species. In
mouse and Xenopus, Pax3 is expressed in premigratory neural crest
along the neural axis, and Pax7 is restricted to cranial levels (and
very weak in Xenopus) [13,28,29]. In chick and zebrafish, Pax7 is
expressed throughout the developing crest, and whereas Pax3
expression in neural crest is restricted to trunk levels in chick, in
zebrafish it is also seen at cranial levels [4,30,31]. Evidence from
Xenopus, mouse and lamprey suggests that Pax3 and/or Pax7 is
required for FoxD3 expression and neural crest specification
[13,22]. In chick, Pax7 but not Pax3 knock-down at gastrula stages
depletes neural crest specifier expression [4]. Mouse Pax3 mutants
have a neural crest phenotype, and lack expression of FoxD3 in
the trunk neural crest. However at cranial levels, where Pax7 is
expressed, FoxD3 also is expressed [13]. Pax7 mutant mice have
some craniofacial abnormalities, but survive well [28], and the
impact of Pax3/Pax7 combined knockout on the neural crest has
not been described. Substitution of Pax3 by Pax7 rescues the
development of the neural crest [26], suggesting that there is
partial redundancy between Pax3 and Pax7 in the mouse neural
crest. In Xenopus, Pax3 is necessary for expression of FoxD3 [22],
and in lamprey the Pax3/7 gene is similarly necessary for
expression of the FoxD3 homolog FoxD-A [23].
Msx1 has been proposed to lie upstream of Pax3, FoxD3 and
Snail2 during neural crest induction in Xenopus [21]. Loss of Msx1
or Msx2 in mice causes craniofacial abnormalities [32,33], while
the combined loss resulted in major defects in cranial neural crest
derivatives, including mispatterning or reduction in size of cranial
ganglia, loss, hypoplasticity or malformation of cranial bones, and
conotruncal abnormalities [34]. Ablation of FoxD3 in mice in
neural crest using Wnt-cre causes a similar phenotype at cranial
levels; loss or reduction of many craniofacial structures, reduction
in the size of cranial ganglia, subtle cardiac neural crest defects and
also reduction in dorsal root ganglia size, and loss of enteric neural
crest [24]. Cranial neural crest cells are still capable of undergoing
migration in the absence of FoxD3 or Msx1/2, but many undergo
apoptosis; in FoxD3 mutants apoptosis was seen in the neural tube
or during migration [24], and in Msx1/2 mutants in the trigeminal
ganglia and branchial arches [34]. As yet, the expression pattern of
FoxD3 in the Msx1/2 mouse mutants is not known; however the
strong similarities between the FoxD3 and Msx1/2 mutants at
cranial levels provide support to the idea that Msx1/2 are
immediately upstream of FoxD3 in the cranial neural crest.
Differences at cranial levels between the mutant mice may reflect
other roles of Msx genes, such as in neural tube and bone
development. Other differences between the phenotypes suggest
that in mice, Msx1/2 is not critical for neural crest development at
trunk levels, unlike FoxD3. Although Msx transcription factors
have been primarily described as transcriptional repressors [35],
there is growing evidence for their role as transcriptional activators
as well [36,37]. Our results demonstrate that during avian cranial
neural crest specification, Msx1/2 act as transcriptional co-
activators of FoxD3.
Our data also show that Ets1 is necessary for initial FoxD3
expression since electroporation of Ets1 morpholinos during
gastrulation (at HH5) depletes FoxD3 expression at HH9. In
contrast, a dominant-negative Ets1 inhibited cranial neural crest
migration but did not result in decreased FoxD3 expression [38].
Examination of the expression of FoxD3 and Ets1 by in situ
hybridization suggests that Ets1 and FoxD3 are expressed
concomitantly in the cranial neural crest. The difference in results
between these two studies likely rests in the stages at which the
knock-down reagents were effective, with the present results
uncovering an earlier role for Ets1.
Recent work on the Sox10E2 enhancer showed that Sox10
expression in the cranial neural crest is regulated by Ets1, Sox9
and cMyb [5,39]. The finding that Ets1 participates in activation
of both FoxD3 and Sox10 at cranial level solidifies its potential
crucial activation role in regulation of the cranial neural crest as a
factor that initiates the specification module of the neural crest
gene regulatory network. Interestingly, mis-expression of Ets1 in
trunk levels confers cranial neural crest-like characteristics on
trunk neural tube cells; namely increased delamination of neural
crest independent of cell cycle phase [38]. This suggests that it
plays a critical role in conferring head/trunk differences in the
neural crest. However, conservation of this regulation across
vertebrates remains to be determined. Ets1 is expressed by
premigratory and migratory cranial neural crest in mice [40] and
Xenopus [41]. Mice null for Ets1 have defects in cardiac neural
crest, but none reported in cranial neural crest [40,42]. Whether
there is compensation for Ets1 in the cranial neural crest by other
family members remains to be determined. Ets1 expression in
chick neural crest is restricted to cranial levels; R4 and more
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rostral regions [38,43]. Interestingly, the NC1 enhancer for FoxD3
is not active in R4, whereas the Sox10E2 enhancer is active to R6
[5], and Ets1 is active in R4 but not further caudally [38].
Although there is little published information regarding the
molecular players are involved in the establishment of the more
caudal neural crest populations, the present results implicate the
neural plate border specifier, Zic1, as a critical factor in the control
of FoxD3 expression at vagal and trunk levels. Zic1 has been
shown to be required for FoxD3 expression in Xenopus neural crest
[21,22] where it is likely to partner with Pax3 in neural crest
specification. Conversely, over-expression of Zic1 causes expan-
sion of the FoxD3 and Snail2 expression domains [22], albeit it is
unclear whether this occurs via direct or secondary interactions.
The role of Zic1 as a trunk specific activator of FoxD3 is
corroborated by expression data (Simo˜es-Costa M., unpublished
observations) suggesting much higher Zic1 transcript levels in the
vagal/trunk avian neural folds than at cranial levels at the onset of
FoxD3 expression. Our results are consistent with complementary
functions of Zic1 in trunk and Ets1 in cranial neural crest
specification in the avian embryo.
The present study expands the number of known direct
regulatory interactions in the cranial neural crest gene regulatory
network, confirming a direct regulation of FoxD3 by Pax3/7 and
Msx1/2, and revealing a previously unknown regulation of FoxD3
by Ets1. We have also identified Zic1 as a key player in setting up
the FoxD3 expression domain in the trunk neural crest. Several
other genes, like Hairy2, Sox10 and Sox5, have been suggested to
regulate FoxD3 expression [44–46]; however it remains to be
determined whether this regulation is direct or indirect.
Differential control of head versus trunk neural crest
It is well known that the developmental potential of neural crest
cells varies along different levels of the neural axis. Quail/chick
chimeras have elegantly demonstrated that both the pathways of
migration and derivatives differ depending upon the axial level
from which neural crest cells emigrate [47]. For example, cranial
but not trunk neural crest cells normally contribute to bone and
cartilage. Similarly, vagal neural crest cells contribute to the
enteric nervous system whereas other neural crest populations
normally do not [48].
Our data show that the inputs to FoxD3 in the vagal/trunk
region are distinct from those functioning at cranial levels,
suggesting a model for region-specific expression of FoxD3
(Figure 7). Whereas the neural plate border specifier Zic1 appears
to be a critical input for NC2 activity in the trunk, Ets1 is critical
for activating NC1 at cranial levels. Both Zic1 and Ets1
transcription factors appear to act in concert with Pax7 and
Msx1/2 which are expressed along the entire neural axis. To date,
no transcription factors have been found to be selectively
expressed in particular regions of the premigratory neural crest.
However, the discovery of cranial-specific enhancers for FoxD3
(this study) and Sox10 [5] clearly suggest that these differences are
inherent at the regulatory level. The existence of these enhancers
supports the idea that both spatial and temporal information is
encoded in the genome.
Materials and Methods
Enhancer constructs
The genomic region of chicken FoxD3 was compared to other
vertebrates using the ECR Browser (http://ecrbrowser.dcode.org)
and comparative analysis tracks of UCSC Genome Browser
(http://genome.ucsc.edu/). We analyzed a 160 kb genomic region
encompassing the FoxD3 locus up to the first upstream (Atg4C)
and downstream (Alg6) of neighboring genes. Regions containing
elements found to be highly conserved across most vertebrates
including human, mouse and Xenopus were amplified using Expand
High Fidelity Plus system (Roche, Indianapolis, IN) with CH261-
166E22 and CH261-100C15 (CHORI BAC Resources, http://
bacpac.chori.org) BAC clones as templates and directionally
cloned into the ptkeGFP or ptkCherry vectors [5,17]. Mouse
neural crest enhancers mNC1 and mNC2 were amplified using
Expand High Fidelity Plus system from genomic cDNA. For use in
multiple enhancer time-lapse experiments, ptkCitrine and ptkCer-
ulean plasmids were constructed by swapping the eGFP coding
region by Citrine and Cerulean sequences, respectively. Appro-
priate enhancer elements (Sox10E from [5] and NC1, NC2 – this
study) were cloned into ptkCherry, ptkCitrine and ptkCerulean,
respectively.
Electroporation and time-lapse imaging of slice cultures
Chicken embryos were electroporated at HH4 using previously
described techniques [1,49]. FITC-conjugated morpholinos
(against target factors or control morpholino) at concentrations
from 1–3 mM combined with 1 mg/ml of enhancer_reporter
Cherry constructs were electroporated only on one half of the
embryo. For morpholino knockdown of regulators, electropora-
tions were performed at HH5 or HH5+ to avoid disruption of the
neural plate border. Fifteen to twenty embryos were analyzed for
each of the morpholinos used. To electroporate HH8–14 chicken
embryos in ovo, previously described techniques [50] were used
with minor modifications; both constructs were injected at a
concentration of 2 mg/ml each, and embryos were electroporated
with 5 30ms-square pulses of 22 V with 100 ms rest in between
each pulse. After incubation, embryos were collected and fixed in
4% paraformaldehyde for 1 hour, then viewed using fluorescence
microscopy. Images were captured using a Zeiss Axioskop 2 plus
microscope with AxioVision 4.6 software, and compiled using
Adobe Photoshop 7.0 and Adobe Illustrator 10. For dynamic
multiple enhancer analysis in slice culture, embryos were
electroporated at stage HH4 with three constructs simultaneously
(Sox10E-Cherry/NC1-Citrine/NC2-Cerulean) to allow for prop-
er spectral separation of reporter signals from different enhancers.
After roughly 16 hours of incubation, cranial midbrain regions
were prepared and imaged as described previously [18].
In situ hybridization
Whole mount and section in situ hybridization for FoxD3 were
performed using previously described procedures [51]. Whole
mount in situ hybridization for eGFP was modified using the
guidelines in [52]. Double fluorescence in situ hybridization was
performed according to [53], and hybridization chain reaction
(HCR) to detect endogenous FoxD3 was conducted according to
[19].
Antibody labeling and imaging
Some embryos expressing RFP and eGFP were processed and
cryosectioned at 14 mm. Select sections were labeled using the
HNK-1 antibody (diluted 1/50), secondarily detected using goat
anti-mouse IgM Alexa 350 (1/200; Molecular Probes). For whole
mount immunostaining we used the protocol described by [54]
(FoxD3 antibody generously provided by Patricia Labosky and
Michelle Southard-Smith).
Enhancer substitutions and mutations
Regions of NC1 and NC2 were replaced with eGFP coding
sequence using fusion PCR protocol. For 100 bp substitutions, the
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region of eGFP used was tggagtacaactacaacagccacaacgtctatat-
catggccgacaagcagaagaacgg catcaaggtgaacttcaagatccgccacaacatc-
gaggacgg, for 30 bp substitutions acaagcagaagaacggcatcaaggtgaact
and for 20 bp substitutions tggagtacaactacaacagc. Fragments were
amplified using primers detailed in Table S2 and fused using the
method adapted from [55]. Amplified fusion fragments were
cloned into ptkeGFP and sequenced to ensure no additional
mutations were present. ECR browser (http://rvista.dcode.org/)
and Jaspar database (http://jaspar.genereg.net/cgi-bin/
jaspar_db.pl) were used to predict and analyze binding motifs
within highly conserved regions. Individual sites were mutated by
substituting 6–8 adjacent critical base pairs with GFP coding
sequence, using fusion PCR and sub-cloning into ptkeGFP.
Primers used are listed in Table S3. Mutated enhancer constructs
were electroporated into stage HH4 embryos as described above
and analyzed for expression of eGFP and RFP at stages HH8–12.
A minimum of five embryos was examined for each condition.
Chromatin immunoprecipitation
ChIP was performed using chromatin prepared from dorsal
neural tube regions of HH8–10 (4–10 somite) chicken embryos
using Ets1 (sc-350;Santa Cruz), Pax7 (ab34360. Abcam) and Msx1
antibodies (Sigma M0944) with normal rabbit IgGs (sc-2027,Santa
Cruz;ab27478, Abcam) as previously described [56]. For the Zic1
ChIP chromatin was isolated from the dorsal neural tube regions
from the trunk of HH11 embryos. Immunoprecipitation was
performed with a Zic1 antibody from Sigma (HPA004098).
Supporting Information
Figure S1 Expression of NC2 in dorsal root ganglia, melano-
cytes and enteric nervous system. (A) In situ hybridization for
FoxD3 showing expression in a dorsal root ganglion (DRG)
adjacent to the neural tube (NT) in the trunk. No FoxD3
expression is present underneath the ectoderm where melanocytes
Figure 7. Model for differential regulation of FoxD3 in cranial and trunk neural crest cell populations. FoxD3 expression is controlled by
distinct inputs and enhancers at different axial levels. Ets1 is critical for activating NC1 at cranial levels, while the neural plate border specifier, Zic1, is
required for NC2 activity in the trunk. Both Zic1 and Ets1 transcription factors appear to act in concert with Pax7 and Msx1/2 that are expressed along
the entire neural axis.
doi:10.1371/journal.pgen.1003142.g007
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are localized. (B) Transverse section through the trunk region
similar to that shown in (A). eGFP (green) driven by enhancer
NC2 is observed in the DRG as well as underneath the ectoderm
(arrows) in presumptive melanocytes on the dorsolateral pathway.
(C) Whole mount view of NC2 driven eGFP activity at HH19.
Expression can be seen in the dorsal root ganglia (arrow) and
melanoblasts (arrowheads). (D) In situ hybridization for eGFP
shows expression in DRGs (arrow) and melanoblasts (arrowheads).
(E) Transverse section of (D) confirms expression of eGFP in
migrating melanoblasts (arrows). (F) NC2 activity can be seen in
neural crest cells in the gut at HH27.
(TIF)
Figure S2 Putative transcription factor binding sites in the NC1
core region were subsequently mutated to examine effects on
activity. (A) Core region of the enhancer with several binding sites
highlighted. Mutation of sites in blue had no effect on the activity
of the enhancer; sites in red abolished activity of enhancer when
mutated. Results of two of the mutations are shown at HH9. eGFP
expression (green) indicates activity of the enhancer in electropo-
rated (red) cells. Faint background fluorescence can be seen in the
neural tube and neural crest. (B,C) Mutation of the Ets/Zeb site
did not abolish eGFP activity in the neural crest. (D,E) Mutation of
the homeodomain (HD) site abolished activity in the cranial neural
crest, resulting in a small number of cells weakly expressing eGFP.
(TIF)
Figure S3 Sox9 and HNK-1 expression in neural crest persists
after knock-down of Pax7, Msx1/2 and Ets1 morpholinos. (A–C)
Embryos in which NC1 enhancer-driven Cherry was depleted via
knockdown of Pax7, Msx1/2 and Ets1 (see Figure 4) were
analyzed for expression of neural crest markers, Sox9 and HNK-1
epitope, even though endogenous FoxD3 was down-regulated (D–
F). Sox9 expression was only slightly reduced (G–I), indicating
neural crest cells were present in morpholino-treated embryos. (J–
L) Immunostaining with the HNK-1 antibody at stage HH10
confirmed the presence of neural crest cells after morpholino
treatment.
(TIF)
Table S1 Mutational analysis of the NC2 enhancer reveals
importance of Zic binding sites. Mutation M11, which impairs a
Zic binding site, causes complete loss of trunk NC2 activity.
Mutations M11, M15, M18 and M20 suppress cranial NC2
activity but only result in a slight reduction of enhancer expression
in the trunk.
(DOCX)
Table S2 Primers used for NC1, NC2 deletions and substitu-
tions. Text in capitals indicates enhancer sequence, and text in
small letters indicates replacement GFP sequence. To make the
mutated constructs, mutated primers were paired with flanking
primers NC1.1 or NC2.9, amplified and joined in a fusion PCR
reaction using the flanking primers NC1.1 or NC2.9.
(DOCX)
Table S3 Primers used for binding site mutations of NC1. Text
in capitals indicates mutated sequence. To make the mutated
constructs, primers were paired with flanking primers NC1.1,
amplified and joined in a fusion PCR reaction using the flanking
NC1.1 primers.
(DOCX)
Video S1 Dynamic regulation of FoxD3 and Sox10 enhancers in
the cranial neural crest. Time-lapse movie shows differential
temporal and spatial activity of NC1 (green), NC2 (blue) and the
Sox10E2 (red) enhancers in a chick cranial slice preparation. NC1
drives expression of the reporter in the premigratory neural crest,
preceding Sox10E enhancer activity. NC2 activity was observed in
few cells within the neural tube, and few delaminating neural crest
cells in which Sox10E2 is also active.
(M4V)
Video S2 Time lapse movie of migrating cranial neural crest
cells electroporated with NC1:eGFP and NC2:Cherry. Time-lapse
movie shows little overlap between cells with activity of NC1 and
NC2. NC1 is active transiently in early neural crest cells, while
NC2 seems to be primarily responsible for FoxD3 expression in
migratory neural crest at cranial levels.
(M4V)
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